Clinical Trials Directory

Trials / Completed

CompletedNCT02792595

In Vivo Sun Protection Factor Determination

Sun Protection Factor Determination (In Vivo Determination of the Sun Protection Factor ISO 24444) (61-SPF-iM)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The study aims to determine the Sun Protection Factor (SPF) of 8 cosmetic products in vivo on the back of human participants, according to the International Standard Sun Protection Test method by using a sun simulator.

Conditions

Interventions

TypeNameDescription
OTHERNegative ControlUntreated area
OTHERPositive ControlHigh SPF Standard P3/SPF 15
OTHERTest Product AYosemite Falls (Forte Day SPF upgrade) Variant A
OTHERTest Product BYosemite Falls (Forte Day SPF upgrade) Variant B
OTHERTest Product CYosemite Falls (Forte Day SPF upgrade) Variant C
OTHERTest Product DYosemite Falls (Forte Day SPF upgrade) Variant D
OTHERTest Product EYosemite Falls (Forte Day SPF upgrade) Variant E
OTHERTest Product FYosemite Falls (Forte Day SPF upgrade) Variant F
OTHERTest Product GYosemite Falls (Forte Day SPF upgrade) Variant G
OTHERTest Product HYosemite Falls (Forte Day SPF upgrade) Variant H

Timeline

Start date
2015-06-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2016-06-07
Last updated
2016-06-20

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02792595. Inclusion in this directory is not an endorsement.